Table 3.
Demographics of individuals included in the local mRNA levels study.
| AAA | Normal Aorta | p | |
|---|---|---|---|
| n | 89 | 17 | — |
| Age (years) | 71.0 ± 6.6 | 57.5 ± 15.9 | <0.001 |
| Women | 5.6 | 58.8 | <0.001 |
| Aortic diameter (mm) | 65.0 ± 13.0 | — | — |
| Dyslipidemia | 60.7 | 17.6 | 0.003 |
| HTN | 71.9 | 17.6 | <0.001 |
| Diabetes | 23.6 | 11.8 | 0.447 |
| Smokers | 27.0 | 11.8 | 0.305 |
| PAD | 49.4 | 0.0 | <0.001 |
| BVD | 7.9 | 11.8 | 0.957 |
| IHD | 24.7 | 0.0 | 0.048 |
| COPD | 19.1 | 0.0 | 0.108 |
| Antiplatelet users | 59.6 | 11.8 | <0.001 |
| Statin users | 68.5 | 5.9 | <0.001 |
| NSAID users | 4.5 | 0.0 | 0.843 |
| Corticoid users | 4.5 | 0.0 | 0.843 |
| Immuno-supressors users | 4.5 | 0.0 | 0.843 |
Nominal variables are presented as %. Continuous variables are presented as mean ± SD. Due to the nature of normal aorta samples some of the clinical characteristics are not always recorded and infra-evaluation of them is probable. BVD, brain-vascular disease; COPD, chronic occlusive pulmonary disease; HTN, chronic hypertension; IHD, ischemic heart disease; PAD, peripheral artery disease.